nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—Gallbladder disorder—Varenicline—nicotine dependence	0.0439	0.0668	CcSEcCtD
Progesterone—Rash generalised—Varenicline—nicotine dependence	0.017	0.0258	CcSEcCtD
Progesterone—Pancreatitis acute—Varenicline—nicotine dependence	0.0156	0.0237	CcSEcCtD
Progesterone—Transient ischaemic attack—Varenicline—nicotine dependence	0.0143	0.0217	CcSEcCtD
Progesterone—Night sweats—Varenicline—nicotine dependence	0.0134	0.0203	CcSEcCtD
Progesterone—Vaginal discharge—Varenicline—nicotine dependence	0.0118	0.018	CcSEcCtD
Progesterone—Toothache—Varenicline—nicotine dependence	0.0118	0.018	CcSEcCtD
Progesterone—CYP2A6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0109	0.04	CbGpPWpGaD
Progesterone—Menstrual disorder—Varenicline—nicotine dependence	0.0106	0.0161	CcSEcCtD
Progesterone—Suicidal ideation—Varenicline—nicotine dependence	0.0103	0.0156	CcSEcCtD
Progesterone—Thrombosis—Varenicline—nicotine dependence	0.0102	0.0155	CcSEcCtD
Progesterone—Menorrhagia—Varenicline—nicotine dependence	0.00974	0.0148	CcSEcCtD
Progesterone—Endocrine disorder—Varenicline—nicotine dependence	0.00869	0.0132	CcSEcCtD
Progesterone—Acne—Varenicline—nicotine dependence	0.00856	0.013	CcSEcCtD
Progesterone—Disturbance in attention—Varenicline—nicotine dependence	0.00832	0.0127	CcSEcCtD
Progesterone—Tenderness—Varenicline—nicotine dependence	0.00826	0.0126	CcSEcCtD
Progesterone—Aggression—Varenicline—nicotine dependence	0.0082	0.0125	CcSEcCtD
Progesterone—Accidental injury—Varenicline—nicotine dependence	0.00814	0.0124	CcSEcCtD
Progesterone—Viral infection—Varenicline—nicotine dependence	0.00798	0.0121	CcSEcCtD
Progesterone—Nocturia—Varenicline—nicotine dependence	0.00777	0.0118	CcSEcCtD
Progesterone—Dysarthria—Varenicline—nicotine dependence	0.00762	0.0116	CcSEcCtD
Progesterone—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00744	0.0273	CbGpPWpGaD
Progesterone—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.00737	0.0271	CbGpPWpGaD
Progesterone—Musculoskeletal pain—Varenicline—nicotine dependence	0.00729	0.0111	CcSEcCtD
Progesterone—Blood pressure increased—Varenicline—nicotine dependence	0.00721	0.011	CcSEcCtD
Progesterone—Pulmonary embolism—Varenicline—nicotine dependence	0.00721	0.011	CcSEcCtD
Progesterone—Eructation—Varenicline—nicotine dependence	0.00708	0.0108	CcSEcCtD
Progesterone—Influenza like illness—Varenicline—nicotine dependence	0.007	0.0106	CcSEcCtD
Progesterone—CYP2A6—Xenobiotics—CYP2A7—nicotine dependence	0.00675	0.0248	CbGpPWpGaD
Progesterone—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00664	0.0244	CbGpPWpGaD
Progesterone—Hypertonia—Varenicline—nicotine dependence	0.00632	0.00961	CcSEcCtD
Progesterone—Mental disability—Varenicline—nicotine dependence	0.00625	0.00951	CcSEcCtD
Progesterone—Lymphadenopathy—Varenicline—nicotine dependence	0.00613	0.00933	CcSEcCtD
Progesterone—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00611	0.0224	CbGpPWpGaD
Progesterone—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00606	0.0223	CbGpPWpGaD
Progesterone—Sleep disorder—Varenicline—nicotine dependence	0.00604	0.00919	CcSEcCtD
Progesterone—Disorientation—Varenicline—nicotine dependence	0.00585	0.0089	CcSEcCtD
Progesterone—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00582	0.0214	CbGpPWpGaD
Progesterone—CYP17A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00574	0.0211	CbGpPWpGaD
Progesterone—Injury—Varenicline—nicotine dependence	0.00569	0.00866	CcSEcCtD
Progesterone—Libido decreased—Varenicline—nicotine dependence	0.00564	0.00858	CcSEcCtD
Progesterone—Hot flush—Varenicline—nicotine dependence	0.00559	0.00851	CcSEcCtD
Progesterone—Increased appetite—Varenicline—nicotine dependence	0.00557	0.00847	CcSEcCtD
Progesterone—Menopausal symptoms—Varenicline—nicotine dependence	0.00554	0.00843	CcSEcCtD
Progesterone—Visual disturbance—Varenicline—nicotine dependence	0.00552	0.0084	CcSEcCtD
Progesterone—Thirst—Varenicline—nicotine dependence	0.0055	0.00836	CcSEcCtD
Progesterone—Arthritis—Varenicline—nicotine dependence	0.00538	0.00819	CcSEcCtD
Progesterone—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00533	0.0196	CbGpPWpGaD
Progesterone—Osteoarthritis—Varenicline—nicotine dependence	0.00523	0.00796	CcSEcCtD
Progesterone—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00519	0.00789	CcSEcCtD
Progesterone—Affect lability—Varenicline—nicotine dependence	0.00515	0.00783	CcSEcCtD
Progesterone—Migraine—Varenicline—nicotine dependence	0.00515	0.00783	CcSEcCtD
Progesterone—CYP1A1—Xenobiotics—CYP2A7—nicotine dependence	0.00503	0.0185	CbGpPWpGaD
Progesterone—Irritability—Varenicline—nicotine dependence	0.00499	0.00759	CcSEcCtD
Progesterone—Mood swings—Varenicline—nicotine dependence	0.00496	0.00754	CcSEcCtD
Progesterone—Liver function test abnormal—Varenicline—nicotine dependence	0.00483	0.00735	CcSEcCtD
Progesterone—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00477	0.0175	CbGpPWpGaD
Progesterone—Breast disorder—Varenicline—nicotine dependence	0.00473	0.00719	CcSEcCtD
Progesterone—CYP17A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00471	0.0173	CbGpPWpGaD
Progesterone—Cramp muscle—Varenicline—nicotine dependence	0.00471	0.00717	CcSEcCtD
Progesterone—Nasopharyngitis—Varenicline—nicotine dependence	0.00468	0.00712	CcSEcCtD
Progesterone—Gastritis—Varenicline—nicotine dependence	0.00463	0.00704	CcSEcCtD
Progesterone—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00461	0.0169	CbGpPWpGaD
Progesterone—Abdominal distension—Varenicline—nicotine dependence	0.00455	0.00692	CcSEcCtD
Progesterone—Dysphagia—Varenicline—nicotine dependence	0.00452	0.00688	CcSEcCtD
Progesterone—Asthma—Varenicline—nicotine dependence	0.00452	0.00688	CcSEcCtD
Progesterone—Angina pectoris—Varenicline—nicotine dependence	0.0044	0.0067	CcSEcCtD
Progesterone—SHBG—cardiovascular system—nicotine dependence	0.00437	0.0621	CbGeAlD
Progesterone—Bronchitis—Varenicline—nicotine dependence	0.00435	0.00661	CcSEcCtD
Progesterone—Abdominal discomfort—Varenicline—nicotine dependence	0.00433	0.00659	CcSEcCtD
Progesterone—NR3C2—cardiovascular system—nicotine dependence	0.00423	0.0601	CbGeAlD
Progesterone—Pollakiuria—Varenicline—nicotine dependence	0.00418	0.00635	CcSEcCtD
Progesterone—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00412	0.0151	CbGpPWpGaD
Progesterone—Weight increased—Varenicline—nicotine dependence	0.00411	0.00626	CcSEcCtD
Progesterone—Hyperglycaemia—Varenicline—nicotine dependence	0.00408	0.0062	CcSEcCtD
Progesterone—Infestation NOS—Varenicline—nicotine dependence	0.00403	0.00613	CcSEcCtD
Progesterone—Infestation—Varenicline—nicotine dependence	0.00403	0.00613	CcSEcCtD
Progesterone—Depression—Varenicline—nicotine dependence	0.00402	0.00611	CcSEcCtD
Progesterone—PGR—cardiovascular system—nicotine dependence	0.00394	0.0559	CbGeAlD
Progesterone—Conjunctivitis—Varenicline—nicotine dependence	0.00392	0.00596	CcSEcCtD
Progesterone—Hepatobiliary disease—Varenicline—nicotine dependence	0.00381	0.0058	CcSEcCtD
Progesterone—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00379	0.0139	CbGpPWpGaD
Progesterone—Sinusitis—Varenicline—nicotine dependence	0.00378	0.00575	CcSEcCtD
Progesterone—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00375	0.0138	CbGpPWpGaD
Progesterone—Urinary tract disorder—Varenicline—nicotine dependence	0.00357	0.00544	CcSEcCtD
Progesterone—Oedema peripheral—Varenicline—nicotine dependence	0.00356	0.00542	CcSEcCtD
Progesterone—Connective tissue disorder—Varenicline—nicotine dependence	0.00356	0.00541	CcSEcCtD
Progesterone—Urethral disorder—Varenicline—nicotine dependence	0.00355	0.0054	CcSEcCtD
Progesterone—Visual impairment—Varenicline—nicotine dependence	0.00349	0.0053	CcSEcCtD
Progesterone—Erythema multiforme—Varenicline—nicotine dependence	0.00342	0.0052	CcSEcCtD
Progesterone—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00339	0.0125	CbGpPWpGaD
Progesterone—Eye disorder—Varenicline—nicotine dependence	0.00338	0.00514	CcSEcCtD
Progesterone—Tinnitus—Varenicline—nicotine dependence	0.00337	0.00513	CcSEcCtD
Progesterone—Cardiac disorder—Varenicline—nicotine dependence	0.00336	0.00511	CcSEcCtD
Progesterone—CYP1B1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00335	0.0123	CbGpPWpGaD
Progesterone—CYP1B1—cardiovascular system—nicotine dependence	0.00331	0.047	CbGeAlD
Progesterone—NR3C2—midbrain—nicotine dependence	0.00331	0.047	CbGeAlD
Progesterone—SLC10A1—brain—nicotine dependence	0.0033	0.0469	CbGeAlD
Progesterone—Angiopathy—Varenicline—nicotine dependence	0.00328	0.00499	CcSEcCtD
Progesterone—Immune system disorder—Varenicline—nicotine dependence	0.00327	0.00497	CcSEcCtD
Progesterone—Mediastinal disorder—Varenicline—nicotine dependence	0.00326	0.00496	CcSEcCtD
Progesterone—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00321	0.0118	CbGpPWpGaD
Progesterone—Mental disorder—Varenicline—nicotine dependence	0.00317	0.00482	CcSEcCtD
Progesterone—Erythema—Varenicline—nicotine dependence	0.00315	0.00479	CcSEcCtD
Progesterone—Malnutrition—Varenicline—nicotine dependence	0.00315	0.00479	CcSEcCtD
Progesterone—AR—cardiovascular system—nicotine dependence	0.00314	0.0445	CbGeAlD
Progesterone—Flatulence—Varenicline—nicotine dependence	0.0031	0.00472	CcSEcCtD
Progesterone—ESR1—cardiovascular system—nicotine dependence	0.00308	0.0437	CbGeAlD
Progesterone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00306	0.0112	CbGpPWpGaD
Progesterone—Back pain—Varenicline—nicotine dependence	0.00305	0.00464	CcSEcCtD
Progesterone—Muscle spasms—Varenicline—nicotine dependence	0.00303	0.00461	CcSEcCtD
Progesterone—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00302	0.0111	CbGpPWpGaD
Progesterone—Vision blurred—Varenicline—nicotine dependence	0.00297	0.00452	CcSEcCtD
Progesterone—Tremor—Varenicline—nicotine dependence	0.00295	0.00449	CcSEcCtD
Progesterone—Ill-defined disorder—Varenicline—nicotine dependence	0.00292	0.00445	CcSEcCtD
Progesterone—Anaemia—Varenicline—nicotine dependence	0.00291	0.00443	CcSEcCtD
Progesterone—OPRK1—brain—nicotine dependence	0.00291	0.0413	CbGeAlD
Progesterone—Angioedema—Varenicline—nicotine dependence	0.00288	0.00438	CcSEcCtD
Progesterone—CYP17A1—brain—nicotine dependence	0.00288	0.0408	CbGeAlD
Progesterone—Malaise—Varenicline—nicotine dependence	0.00284	0.00432	CcSEcCtD
Progesterone—Vertigo—Varenicline—nicotine dependence	0.00283	0.00431	CcSEcCtD
Progesterone—Syncope—Varenicline—nicotine dependence	0.00283	0.0043	CcSEcCtD
Progesterone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0028	0.0103	CbGpPWpGaD
Progesterone—Palpitations—Varenicline—nicotine dependence	0.00278	0.00423	CcSEcCtD
Progesterone—Loss of consciousness—Varenicline—nicotine dependence	0.00277	0.00421	CcSEcCtD
Progesterone—CYP2A6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00277	0.0102	CbGpPWpGaD
Progesterone—CYP1B1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00275	0.0101	CbGpPWpGaD
Progesterone—Cough—Varenicline—nicotine dependence	0.00275	0.00418	CcSEcCtD
Progesterone—Convulsion—Varenicline—nicotine dependence	0.00273	0.00415	CcSEcCtD
Progesterone—Hypertension—Varenicline—nicotine dependence	0.00272	0.00414	CcSEcCtD
Progesterone—SIGMAR1—midbrain—nicotine dependence	0.00272	0.0386	CbGeAlD
Progesterone—Arthralgia—Varenicline—nicotine dependence	0.00268	0.00408	CcSEcCtD
Progesterone—Myalgia—Varenicline—nicotine dependence	0.00268	0.00408	CcSEcCtD
Progesterone—Chest pain—Varenicline—nicotine dependence	0.00268	0.00408	CcSEcCtD
Progesterone—Anxiety—Varenicline—nicotine dependence	0.00267	0.00407	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00266	0.00405	CcSEcCtD
Progesterone—CYP17A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00266	0.00976	CbGpPWpGaD
Progesterone—Discomfort—Varenicline—nicotine dependence	0.00265	0.00403	CcSEcCtD
Progesterone—Dry mouth—Varenicline—nicotine dependence	0.00262	0.00399	CcSEcCtD
Progesterone—Oedema—Varenicline—nicotine dependence	0.00257	0.00391	CcSEcCtD
Progesterone—Infection—Varenicline—nicotine dependence	0.00255	0.00389	CcSEcCtD
Progesterone—Shock—Varenicline—nicotine dependence	0.00253	0.00385	CcSEcCtD
Progesterone—Nervous system disorder—Varenicline—nicotine dependence	0.00252	0.00384	CcSEcCtD
Progesterone—Tachycardia—Varenicline—nicotine dependence	0.00251	0.00382	CcSEcCtD
Progesterone—CYP17A1—Biological oxidations—CYP2A7—nicotine dependence	0.0025	0.0092	CbGpPWpGaD
Progesterone—Skin disorder—Varenicline—nicotine dependence	0.0025	0.0038	CcSEcCtD
Progesterone—Hyperhidrosis—Varenicline—nicotine dependence	0.00249	0.00378	CcSEcCtD
Progesterone—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00248	0.00911	CbGpPWpGaD
Progesterone—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00248	0.0091	CbGpPWpGaD
Progesterone—CYP17A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00247	0.00907	CbGpPWpGaD
Progesterone—Anorexia—Varenicline—nicotine dependence	0.00245	0.00373	CcSEcCtD
Progesterone—Hypotension—Varenicline—nicotine dependence	0.0024	0.00365	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00234	0.00356	CcSEcCtD
Progesterone—OPRK1—Peptide GPCRs—OPRM1—nicotine dependence	0.00233	0.00855	CbGpPWpGaD
Progesterone—Insomnia—Varenicline—nicotine dependence	0.00233	0.00354	CcSEcCtD
Progesterone—Dyspnoea—Varenicline—nicotine dependence	0.00229	0.00349	CcSEcCtD
Progesterone—Somnolence—Varenicline—nicotine dependence	0.00229	0.00348	CcSEcCtD
Progesterone—CYP2A6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00227	0.00835	CbGpPWpGaD
Progesterone—NR3C1—cardiovascular system—nicotine dependence	0.00227	0.0323	CbGeAlD
Progesterone—Dyspepsia—Varenicline—nicotine dependence	0.00226	0.00344	CcSEcCtD
Progesterone—CYP2C9—cardiovascular system—nicotine dependence	0.00225	0.032	CbGeAlD
Progesterone—Decreased appetite—Varenicline—nicotine dependence	0.00223	0.0034	CcSEcCtD
Progesterone—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00222	0.00338	CcSEcCtD
Progesterone—Fatigue—Varenicline—nicotine dependence	0.00222	0.00337	CcSEcCtD
Progesterone—CYP2A6—brain—nicotine dependence	0.00222	0.0315	CbGeAlD
Progesterone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00221	0.00812	CbGpPWpGaD
Progesterone—Pain—Varenicline—nicotine dependence	0.0022	0.00334	CcSEcCtD
Progesterone—Constipation—Varenicline—nicotine dependence	0.0022	0.00334	CcSEcCtD
Progesterone—OPRK1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00219	0.00805	CbGpPWpGaD
Progesterone—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00218	0.00802	CbGpPWpGaD
Progesterone—SHBG—brain—nicotine dependence	0.00214	0.0304	CbGeAlD
Progesterone—Feeling abnormal—Varenicline—nicotine dependence	0.00212	0.00322	CcSEcCtD
Progesterone—Gastrointestinal pain—Varenicline—nicotine dependence	0.0021	0.0032	CcSEcCtD
Progesterone—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00209	0.00768	CbGpPWpGaD
Progesterone—NR3C2—brain—nicotine dependence	0.00208	0.0295	CbGeAlD
Progesterone—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00206	0.00758	CbGpPWpGaD
Progesterone—Urticaria—Varenicline—nicotine dependence	0.00204	0.00311	CcSEcCtD
Progesterone—Body temperature increased—Varenicline—nicotine dependence	0.00203	0.00309	CcSEcCtD
Progesterone—Abdominal pain—Varenicline—nicotine dependence	0.00203	0.00309	CcSEcCtD
Progesterone—PGR—brain—nicotine dependence	0.00193	0.0274	CbGeAlD
Progesterone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00192	0.00704	CbGpPWpGaD
Progesterone—Hypersensitivity—Varenicline—nicotine dependence	0.00189	0.00288	CcSEcCtD
Progesterone—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00189	0.00694	CbGpPWpGaD
Progesterone—SLC22A1—brain—nicotine dependence	0.00185	0.0263	CbGeAlD
Progesterone—Asthenia—Varenicline—nicotine dependence	0.00184	0.00281	CcSEcCtD
Progesterone—AR—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00183	0.00671	CbGpPWpGaD
Progesterone—Pruritus—Varenicline—nicotine dependence	0.00182	0.00277	CcSEcCtD
Progesterone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00179	0.00659	CbGpPWpGaD
Progesterone—NR3C1—midbrain—nicotine dependence	0.00177	0.0252	CbGeAlD
Progesterone—SLC22A3—brain—nicotine dependence	0.00177	0.0251	CbGeAlD
Progesterone—Diarrhoea—Varenicline—nicotine dependence	0.00176	0.00268	CcSEcCtD
Progesterone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00171	0.00628	CbGpPWpGaD
Progesterone—SIGMAR1—brain—nicotine dependence	0.00171	0.0243	CbGeAlD
Progesterone—SLC22A2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0017	0.00625	CbGpPWpGaD
Progesterone—Dizziness—Varenicline—nicotine dependence	0.0017	0.00259	CcSEcCtD
Progesterone—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00169	0.00622	CbGpPWpGaD
Progesterone—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00169	0.0062	CbGpPWpGaD
Progesterone—Vomiting—Varenicline—nicotine dependence	0.00163	0.00249	CcSEcCtD
Progesterone—CYP1B1—brain—nicotine dependence	0.00162	0.0231	CbGeAlD
Progesterone—Rash—Varenicline—nicotine dependence	0.00162	0.00247	CcSEcCtD
Progesterone—Dermatitis—Varenicline—nicotine dependence	0.00162	0.00246	CcSEcCtD
Progesterone—SLC22A2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00161	0.00592	CbGpPWpGaD
Progesterone—Headache—Varenicline—nicotine dependence	0.00161	0.00245	CcSEcCtD
Progesterone—SLC22A1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00159	0.00583	CbGpPWpGaD
Progesterone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00157	0.00578	CbGpPWpGaD
Progesterone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00156	0.00573	CbGpPWpGaD
Progesterone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00155	0.0057	CbGpPWpGaD
Progesterone—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00155	0.0057	CbGpPWpGaD
Progesterone—CYP1B1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00155	0.00569	CbGpPWpGaD
Progesterone—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00154	0.00565	CbGpPWpGaD
Progesterone—AR—brain—nicotine dependence	0.00154	0.0219	CbGeAlD
Progesterone—Nausea—Varenicline—nicotine dependence	0.00153	0.00232	CcSEcCtD
Progesterone—ESR1—brain—nicotine dependence	0.00151	0.0215	CbGeAlD
Progesterone—SLC22A1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0015	0.00552	CbGpPWpGaD
Progesterone—ABCC1—brain—nicotine dependence	0.00146	0.0208	CbGeAlD
Progesterone—CYP1B1—Biological oxidations—CYP2A7—nicotine dependence	0.00146	0.00537	CbGpPWpGaD
Progesterone—CYP1B1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00144	0.00529	CbGpPWpGaD
Progesterone—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0014	0.00513	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00139	0.00509	CbGpPWpGaD
Progesterone—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00139	0.00509	CbGpPWpGaD
Progesterone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00133	0.00489	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00133	0.00487	CbGpPWpGaD
Progesterone—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00132	0.00484	CbGpPWpGaD
Progesterone—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00131	0.00483	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—CHRNB3—nicotine dependence	0.0013	0.00479	CbGpPWpGaD
Progesterone—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0013	0.00477	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—CCAR1—nicotine dependence	0.0013	0.00476	CbGpPWpGaD
Progesterone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00127	0.00468	CbGpPWpGaD
Progesterone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00126	0.00464	CbGpPWpGaD
Progesterone—CYP2C8—brain—nicotine dependence	0.00124	0.0177	CbGeAlD
Progesterone—SLC22A2—Neuronal System—CHRNA6—nicotine dependence	0.00124	0.00454	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00122	0.00448	CbGpPWpGaD
Progesterone—ABCB1—cardiovascular system—nicotine dependence	0.00122	0.0173	CbGeAlD
Progesterone—SLC22A1—Neuronal System—CHRNB3—nicotine dependence	0.00121	0.00446	CbGpPWpGaD
Progesterone—CYP2A6—Biological oxidations—CYP2A7—nicotine dependence	0.00121	0.00444	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00117	0.00428	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—CHRNA6—nicotine dependence	0.00115	0.00423	CbGpPWpGaD
Progesterone—CYP1A1—brain—nicotine dependence	0.00115	0.0163	CbGeAlD
Progesterone—SLC22A2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00112	0.00411	CbGpPWpGaD
Progesterone—NR3C1—brain—nicotine dependence	0.00111	0.0158	CbGeAlD
Progesterone—AR—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00111	0.00407	CbGpPWpGaD
Progesterone—OPRK1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.0011	0.00402	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00109	0.00399	CbGpPWpGaD
Progesterone—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00108	0.00397	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00104	0.00383	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00104	0.00382	CbGpPWpGaD
Progesterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00103	0.00378	CbGpPWpGaD
Progesterone—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00101	0.00373	CbGpPWpGaD
Progesterone—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00101	0.00371	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000969	0.00356	CbGpPWpGaD
Progesterone—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000955	0.00351	CbGpPWpGaD
Progesterone—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.000952	0.0035	CbGpPWpGaD
Progesterone—ABCB1—midbrain—nicotine dependence	0.000949	0.0135	CbGeAlD
Progesterone—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000939	0.00345	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000925	0.0034	CbGpPWpGaD
Progesterone—OPRK1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000924	0.00339	CbGpPWpGaD
Progesterone—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.0009	0.00331	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—GABRA4—nicotine dependence	0.000893	0.00328	CbGpPWpGaD
Progesterone—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000887	0.00326	CbGpPWpGaD
Progesterone—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000875	0.00321	CbGpPWpGaD
Progesterone—OPRK1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000857	0.00315	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—CHRNB4—nicotine dependence	0.000857	0.00315	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000847	0.00311	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00084	0.00309	CbGpPWpGaD
Progesterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000834	0.00306	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—GABRA4—nicotine dependence	0.000833	0.00306	CbGpPWpGaD
Progesterone—CYP2D6—brain—nicotine dependence	0.000829	0.0118	CbGeAlD
Progesterone—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000825	0.00303	CbGpPWpGaD
Progesterone—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000814	0.00299	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—CHRNB4—nicotine dependence	0.000798	0.00293	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—CHRNA5—nicotine dependence	0.000796	0.00293	CbGpPWpGaD
Progesterone—PGR—Gene Expression—CCAR1—nicotine dependence	0.00079	0.0029	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00079	0.0029	CbGpPWpGaD
Progesterone—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000781	0.00287	CbGpPWpGaD
Progesterone—SLC22A3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000766	0.00281	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00075	0.00275	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000746	0.00274	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—CHRNA5—nicotine dependence	0.000742	0.00273	CbGpPWpGaD
Progesterone—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000736	0.0027	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000735	0.0027	CbGpPWpGaD
Progesterone—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000726	0.00267	CbGpPWpGaD
Progesterone—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000718	0.00264	CbGpPWpGaD
Progesterone—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000712	0.00262	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000695	0.00255	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000681	0.0025	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000677	0.00249	CbGpPWpGaD
Progesterone—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000677	0.00249	CbGpPWpGaD
Progesterone—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000671	0.00247	CbGpPWpGaD
Progesterone—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000668	0.00245	CbGpPWpGaD
Progesterone—OPRK1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000668	0.00245	CbGpPWpGaD
Progesterone—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000662	0.00243	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—CHRNA3—nicotine dependence	0.000649	0.00238	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000631	0.00232	CbGpPWpGaD
Progesterone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00062	0.00228	CbGpPWpGaD
Progesterone—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000609	0.00224	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—CHRNA3—nicotine dependence	0.000605	0.00222	CbGpPWpGaD
Progesterone—AR—Gene Expression—CCAR1—nicotine dependence	0.000602	0.00221	CbGpPWpGaD
Progesterone—ABCB1—brain—nicotine dependence	0.000597	0.00847	CbGeAlD
Progesterone—OPRK1—GPCR downstream signaling—FGD1—nicotine dependence	0.000588	0.00216	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—CYP2A7—nicotine dependence	0.000583	0.00214	CbGpPWpGaD
Progesterone—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000574	0.00211	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—CHRNB2—nicotine dependence	0.000571	0.0021	CbGpPWpGaD
Progesterone—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000566	0.00208	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—OPRM1—nicotine dependence	0.000559	0.00205	CbGpPWpGaD
Progesterone—ABCC1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000552	0.00203	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—FGD1—nicotine dependence	0.000534	0.00196	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—CHRNB2—nicotine dependence	0.000533	0.00196	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000531	0.00195	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—CHRNA4—nicotine dependence	0.000519	0.00191	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TAS2R16—nicotine dependence	0.000514	0.00189	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—CHRNA4—nicotine dependence	0.000484	0.00178	CbGpPWpGaD
Progesterone—SLC22A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00048	0.00176	CbGpPWpGaD
Progesterone—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00047	0.00173	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—CCAR1—nicotine dependence	0.000464	0.0017	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—CCAR1—nicotine dependence	0.000457	0.00168	CbGpPWpGaD
Progesterone—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000448	0.00164	CbGpPWpGaD
Progesterone—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000443	0.00163	CbGpPWpGaD
Progesterone—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000437	0.0016	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—CYP2A7—nicotine dependence	0.000428	0.00157	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	0.000404	0.00149	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—FGD1—nicotine dependence	0.000403	0.00148	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	0.000402	0.00148	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—CYP2A7—nicotine dependence	0.000359	0.00132	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKR1B10—nicotine dependence	0.000356	0.00131	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—CYP2A7—nicotine dependence	0.000344	0.00126	CbGpPWpGaD
Progesterone—ABCC1—Disease—AKR1B10—nicotine dependence	0.000332	0.00122	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000316	0.00116	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—FGD1—nicotine dependence	0.000316	0.00116	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TAS2R16—nicotine dependence	0.000301	0.00111	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	0.000287	0.00105	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	0.000279	0.00102	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000262	0.000964	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—CYP2A7—nicotine dependence	0.000258	0.000949	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—WASF2—nicotine dependence	0.000251	0.000921	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—CYP2A7—nicotine dependence	0.00025	0.000918	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—WASF1—nicotine dependence	0.00024	0.000883	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—FGD1—nicotine dependence	0.000237	0.000869	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	0.000229	0.00084	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000225	0.000828	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CYP2A7—nicotine dependence	0.000225	0.000826	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—OPRM1—nicotine dependence	0.000217	0.000795	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CYP2A7—nicotine dependence	0.00021	0.00077	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKR1B10—nicotine dependence	0.000209	0.000768	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	0.000208	0.000762	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CYP2A7—nicotine dependence	0.000207	0.000759	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—WASF2—nicotine dependence	0.000196	0.000722	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—WASF1—nicotine dependence	0.000188	0.000692	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	0.00017	0.000623	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000163	0.000598	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—DRD2—nicotine dependence	0.000157	0.000575	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CYP2A7—nicotine dependence	0.000154	0.000565	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—WASF2—nicotine dependence	0.000147	0.000541	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—WASF1—nicotine dependence	0.000141	0.000518	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000141	0.000518	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—OPRM1—nicotine dependence	0.000127	0.000467	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000126	0.000463	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000123	0.000451	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—DRD2—nicotine dependence	0.000123	0.00045	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000116	0.000425	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000115	0.000422	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP2A7—nicotine dependence	9.81e-05	0.00036	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—DRD2—nicotine dependence	9.19e-05	0.000337	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP2A7—nicotine dependence	7.57e-05	0.000278	CbGpPWpGaD
